CD34 and neoplasm: Indeed, the exposure of CD34+ precursors of pDCs and of differentiated pDCs to soluble tumor components could respectively block their differentiation or induce their apoptosis and be at the origin of the decrease in the proportions of pDCs in circulation and in the metastases of patients.